根据一份提交给美国证券交易委员会（SEC）的文件显示，enVVeno Medical Corp. 预计其临床基地的启动工作以及患者入组将在今年晚些时候开始。这一进展标志着公司在新产品或疗法的临床开发道路上迈出了关键一步。
根据一份提交给美国证券交易委员会（SEC）的文件显示，enVVeno Medical Corp. 预计其临床基地的启动工作以及患者入组将在今年晚些时候开始。这一进展标志着公司在新产品或疗法的临床开发道路上迈出了关键一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.